Abstract
All centers of the Italian Pediatric Rheumatology Study Group were asked in 2013 to make a census of patients given etanercept (ETN) after January 2000. Patients were classified in three groups: 1) patients still taking ETN; 2) patients discontinued from ETN for any reasons; 3) patients lost to follow-up while receiving ETN. All three groups received a retrospective assessment; patients in group 1 also underwent a cross-sectional assessment. The preliminary results of this investigation referred to 1019 patients have been listed in this report.
Lingua originale | English |
---|---|
pagine (da-a) | 1239-1240 |
Numero di pagine | 2 |
Rivista | Annals of the Rheumatic Diseases |
Volume | 2015 |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- Juvenile idiopathic arthritis